Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Maruff

Showing results (331-340 of 438) with videos related to

Pageof 44
Sort By:
Frontiers in Aging Neuroscience|January 31, 2022
Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's DiseaseRoos J Jutten, Dorene M Rentz, Jessie F Fu, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|April 5, 2013
Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS)Yen Ying Lim, Judith Jaeger, Karra Harrington, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Research and standardization in Alzheimer's trials: reaching international consensusMaria C Carrillo, Christopher C Rowe, Cassandra Szoeke, et al.
Scientific Reports|November 8, 2024
The interplay of age, gender and amyloid on brain and cognition in mid-life and older adultsLéonie Borne, Renate Thienel, Michelle K Lupton, et al.
Neuropsychology|May 22, 2013
Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's diseaseYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2026
Composite scores to detect and monitor cognitive dysfunction in preclinical and prodromal Alzheimer's disease: A narrative reviewBhargav Tallapragada, Shaun J Markovic, Kieran J Marston, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 22, 2018
Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort StudyRobert H Pietrzak, Simon M Laws, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Pageof 44

Showing results (331-340 of 438) with videos related to

Sort By:
Pageof 44
Frontiers in Aging Neuroscience|January 31, 2022
Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's DiseaseRoos J Jutten, Dorene M Rentz, Jessie F Fu, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|April 5, 2013
Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS)Yen Ying Lim, Judith Jaeger, Karra Harrington, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Research and standardization in Alzheimer's trials: reaching international consensusMaria C Carrillo, Christopher C Rowe, Cassandra Szoeke, et al.
Scientific Reports|November 8, 2024
The interplay of age, gender and amyloid on brain and cognition in mid-life and older adultsLéonie Borne, Renate Thienel, Michelle K Lupton, et al.
Neuropsychology|May 22, 2013
Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's diseaseYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Journal of Alzheimer'S Disease : JAD|March 23, 2026
Composite scores to detect and monitor cognitive dysfunction in preclinical and prodromal Alzheimer's disease: A narrative reviewBhargav Tallapragada, Shaun J Markovic, Kieran J Marston, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 22, 2018
Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort StudyRobert H Pietrzak, Simon M Laws, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Pageof 44